Personalized neoantigen vaccines in urologic malignancies
Competing interests
R.L. has received research support from CG Oncology, Predicine, Valar Labs and Johnson & Johnson, and has served as consultant for BMS, Merck, CG Oncology, ImmunityBio, Pfizer, Johnson&Johnson, AstraZeneca and enGene.
Comments (0)